Baker E, Page M, Torrance J, Grady R
Clin Physiol Biochem. 1985;3(6):277-88.
The mechanism of action of the hydroxamate iron chelators desferrioxamine (DFO), rhodotorulic acid (RHA) and cholylhydroxamic acid (CHA) was studied using rat hepatocytes in culture. Each chelator affected both the uptake and, to a much smaller extent, the release of transferrin-125I-59Fe from the cells. All chelators reduced the 59Fe uptake and incorporation into ferritin in a concentration-dependent manner. Uptake of 59Fe into the membrane (stromal-mitochondrial) fraction was also decreased by DFO and RHA but increased by CHA. Transferrin-125I binding was reduced slightly by DFO and RHA and increased by CHA. All chelators released 59Fe transferrin-125I from hepatocytes prelabelled by incubation with rat transferrin-125I-59Fe and washed before reincubation in the presence of the chelators. DFO decreased membrane 59Fe but had little effect on ferritin-59Fe. RHA decreased 59Fe in both membrane and ferritin fractions. CHA decreased hepatocyte-59Fe but increased 59Fe in the hepatocyte membrane fraction. Higher concentrations of the chelators had little further effect on 59Fe release but promoted transferrin-125I release from hepatocytes. All chelators appeared to act on kinetically important iron pools of limited size and hence are likely to be most effective when given by continuous infusion rather than bolus injection.
使用培养的大鼠肝细胞研究了异羟肟酸铁螯合剂去铁胺(DFO)、红酵母酸(RHA)和胆酰异羟肟酸(CHA)的作用机制。每种螯合剂都影响转铁蛋白 - 125I - 59Fe从细胞中的摄取,并且在小得多的程度上影响其释放。所有螯合剂均以浓度依赖性方式降低59Fe的摄取和掺入铁蛋白。DFO和RHA也降低了59Fe进入膜(基质 - 线粒体)部分的摄取,但CHA使其增加。DFO和RHA略微降低了转铁蛋白 - 125I的结合,而CHA使其增加。所有螯合剂都能从预先用大鼠转铁蛋白 - 125I - 59Fe孵育并在螯合剂存在下重新孵育前洗涤过的肝细胞中释放59Fe转铁蛋白 - 125I。DFO降低了膜59Fe,但对铁蛋白 - 59Fe影响很小。RHA降低了膜和铁蛋白部分中的59Fe。CHA降低了肝细胞 - 59Fe,但增加了肝细胞膜部分中的59Fe。较高浓度的螯合剂对59Fe释放的进一步影响很小,但促进了转铁蛋白 - 125I从肝细胞中的释放。所有螯合剂似乎作用于大小有限的动力学重要铁池,因此当通过持续输注而非大剂量注射给药时可能最有效。